SCHEMBL26042003

SCHEMBL26042003

CCCCc1cc(C2CCN(C)CC2)c(C)cc1N

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
VDR P11473 1/20 0.36
HTR1D P28221 2/20 0.36
HTR1B P28222 2/20 0.36
SKP2 Q13309 1/20 0.35
SLC6A3 Q01959 1/20 0.33
TLR7 Q9NYK1 1/20 0.33
NOS3 P29474 1/20 0.33
NOS1 P29475 1/20 0.33
HTR1F P30939 3/20 0.33
ALOX15 P16050 1/20 0.32
DRD2 P14416 2/20 0.32
HRH4 Q9H3N8 1/20 0.32
DRD4 P21917 1/20 0.32
DRD3 P35462 1/20 0.32
SLC6A4 P31645 1/20 0.32
GNAI3 P08754 1/20 0.31
GNAO1 P09471 1/20 0.31
GNAI1 P63096 1/20 0.31
ASAH1 Q13510 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24328529 0.86 HTR1D (0.39) HTR1DHTR1BNOS3NOS1HTR1F
SCHEMBL26039913 0.82 HTR2C (0.40) VDRSKP2
SCHEMBL26040679 0.81 VDR (0.34) VDRSKP2SLC6A3HRH4
SCHEMBL18698318 0.74 QDPR (0.45) HTR1DHTR1BHTR1FALOX15DRD2
SCHEMBL13548512 0.74 HTR1D (0.40) HTR1DHTR1BTLR7HTR1FALOX15
SCHEMBL30640846 0.72 ALK (0.43) HTR1DHTR1BHTR1F
SCHEMBL17304106 0.72 ALK (0.43) HTR1DHTR1BHTR1F
SCHEMBL18536009 0.72 SKP2 (0.50) VDRSKP2ALOX15
SCHEMBL12635462 0.71 QDPR (0.44) HTR1DHTR1BHTR1FDRD2
SCHEMBL12705449 0.69 HTR1D (0.35) HTR1DHTR1BTLR7HTR1FALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3150592-B1 ALK KINASE INHIBITOR, AND PREPARATION METHOD AND USE THEREOF SHANGHAI EMERALD WELLCARES PHARMACEUTICAL CO LTD (CN) 2023-08-30 EP disclosed